Research Paper Volume 15, Issue 10 pp 4444—4464
Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma
Figure 7. Evaluation of TME in the high-risk and low-risk groups. (A) Relationship between risk score and a series of immune cell types. (B) Correlation between the abundance of immune cells and the six prognostic TRGs. (C) Correlation between risk score and TME scores. TMB (D, E) and CSC (F) in high- and low-risk groups. *p < 0.05; **p < 0.01; and ***p < 0.001.